Rodents with a combination of HFD and streptozotocin (STZ) treatment have been proposed as a desirable T2D model that imitates the natural history and metabolic features of T2D in humans, since HFD exposure is associated with obesity and insulin resistance and STZ injection induces pancreatic beta cells destruction [21]. This evidence concerns the gene INS and type 2 diabetes mellitus.